Image

Asia-Pacific Cardiopulmonary Bypass Accessory Equipment Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Aug 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 293
  • No of Figures: 43
  • Medical Devices
  • Published Report
  • Aug 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 293
  • No of Figures: 43

Asia-Pacific Cardiopulmonary Bypass Accessory Equipment Market, By Product (Oxygenator, ECMO Machine, Pumps, Cannula, Temperature Monitors, Heat Exchanger, Filters, Tubing Clamps, Hemoconcentrators, System Panel, Sensor and Accessories, Cardioplegia Control, Reservoir, Bubble Detector, Electronic Gas Blender, Electrical Venous Occluder, Venous Line Clamp and Accessories), Operation (Manually Operated, Electrically Operated and Battery Operated), Application (Cardiac Surgery, Cardiac Surgery Oxygenators, Acute Respiratory Failure Treatment, Lung Cancer, Transplant Operation and Others), Age (Adult, Geriatric and Pediatric), End User (Hospitals, Cardiac Centers, Research and Academic Institutions, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Third Party Distributor and Retail Sales), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2028   

Asia-Pacific Cardiopulmonary Bypass Accessory Equipment Market Market Analysis and Insights: Asia-Pacific Cardiopulmonary Bypass Accessory Equipment Market

The cardiopulmonary bypass accessory equipment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.3% in the forecast period of 2021 to 2028 and is expected to reach USD 3,745.98 million by 2028. The increasing prevalence of cardiovascular diseases is expected to act as driver for the cardiopulmonary bypass accessory equipment market.

Cardiopulmonary bypass accessory equipment takes over the function of heart and lung during surgery to maintain the required oxygen level in the blood. The blood is then circulated all over the body. The accessory equipment mainly contains oxygenators, pumps, filters, cardioplegia control among others. The equipment removes oxygen-deprived blood from patient’s body and replaces it with oxygen-rich blood. As the equipment act as a support system for the heart and lungs during the surgery, therefore it is also called heart-lung machine.

The growing geriatric population across the globe is expected to act as driver for the cardiopulmonary bypass accessory equipment market. The stringent government regulation is expected to act as a restrain for the growth of the cardiopulmonary bypass accessory equipment market. The increasing awareness program and growing medical tourism are expected to act as an opportunity for the growth of cardiopulmonary bypass accessory equipment market. Shortage of skilled professionals may expected to act as challenge for the growth of cardiopulmonary bypass accessory equipment market

The cardiopulmonary bypass accessory equipment market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the cardiopulmonary bypass accessory equipment market scenario, contact Data Bridge Market Research for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Cardiopulmonary Bypass Accessory Equipment Market Cardiopulmonary Bypass Accessory Equipment Market Scope and Market Size

The cardiopulmonary bypass accessory equipment market is categorized into six notable segments which are based on the product, operation, application, age, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the cardiopulmonary bypass accessory equipment market is segmented into oxygenator, ECMO machine, pumps, cannula, temperature monitors, heat exchanger, filters, tubing clamps, hemoconcentrators, system panel, sensor and accessories, cardioplegia control, reservoir, bubble detector, electronic gas blender, electrical venous occluder, venous line clamp and accessories. In 2021, oxygenators segment is expected to dominate the market due to the high prevalence of cardiovascular diseases and growing awareness initiatives by the government.
  • On the basis of operation, the cardiopulmonary bypass accessory equipment market is segmented into manually operated, electrically operated and battery operated. In 2021, manually operated segment is expected to dominate the market due to rising demand in market and its efficacy in its application.
  • On the basis of application, the cardiopulmonary bypass accessory equipment market is segmented into cardiac surgery, cardiac surgery oxygenators, acute respiratory failure treatment, lung cancer, transplant operation and others. In 2021, cardiac surgery segment is expected to dominate market because due to the rising number of cardiac surgeries performed across the globe.
  • On the basis of age, the cardiopulmonary bypass accessory equipment market is segmented into adult, geriatric and pediatric. In 2021, adult segment is expected to dominate market because due to the rising cardiopulmonary disease prevalence.
  • On the basis of end user, the cardiopulmonary bypass accessory equipment market is segmented into hospitals, cardiac centers, research and academic institutions, ambulatory surgical centers and others. In 2021, hospitals segment is expected to dominate the market due to the growing demand of the products in the market and strategic initiatives taken by manufacturers to expand the market.
  • On the basis of distribution channel, the cardiopulmonary bypass accessory equipment market is segmented into direct tender, third party distributor and retail sales. In 2021, direct tender segment is expected to dominate the market because of large number of players in the market.

Asia-Pacific Cardiopulmonary Bypass Accessory Equipment Market Country Level Analysis

Asia-Pacific cardiopulmonary bypass accessory equipment market is analysed and market size information is provided by the country, product, operation, application, age, end user and distribution channel as referenced above.

The countries covered in the Asia-Pacific cardiopulmonary bypass accessory equipment market report are the China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific.

China is expected to dominate in the Asia-Pacific cardiopulmonary bypass accessory equipment market due to the increased awareness regarding the treatment and advanced technology adoption. The adult segment is expected to dominate the cardiopulmonary bypass accessory equipment market because due to the strategic decisions taken by key players in the market and growing public-private funding to support and create awareness towards treatment of cardiac diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. 

Technological development along with public-private funding are creating opportunities in the cardiopulmonary bypass accessory equipment market 

The cardiopulmonary bypass accessory equipment market also provides you with detailed market analysis for every country growth in particular industry with cardiopulmonary bypass accessory equipment sales, impact of advancement in the cardiopulmonary bypass accessory equipment market, changes in regulatory scenarios with their support for the cardiopulmonary bypass accessory equipment market. The data is available for historic period 2010 to 2019.

Competitive landscape and Asia-Pacific cardiopulmonary bypass accessory equipment share analysis

Asia-Pacific cardiopulmonary bypass accessory equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance and technology lifeline curve. The above data points provided are only related to the company’s focus related to the Asia-Pacific cardiopulmonary bypass accessory equipment market.

The major companies dealing in the Asia-Pacific cardiopulmonary bypass accessory equipment market are Medtronic, LivaNova PLC, MERA, Technowood International Pte. Ltd., Narang Medical Limited, EUROSETS, Teleflex Incorporated, Getinge AB, Terumo Corporation, Abbott, Edwards Lifesciences Corporation, SCHNELL MEDICAL CORP., NIPRO, XENIOS AG (a subsidiary of Fresenius Medical Care AG & Co. KGaA), Advin Health Care, Boston Scientific Corporation, APC Cardiovascular Ltd, MicroPort Scientific Corporation, Jarvik Heart, Inc., ABIOMED among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players along with new technological advancements for cardiopulmonary bypass accessory equipment are bridging the gap for various treatments.

For instance,

  • In June 2021, ABIOMED announced that it has received FDA premarket approval for Impella RP with Smart Assist a safe and effective to treat acute heart failure. This will help the company to increase its revenue.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the cardiopulmonary bypass accessory equipment market, which also provides the benefit for the organization to improve their offering for cardiopulmonary bypass accessory equipment.

 


SKU-

Why Choose Us


Frequently Asked Questions